Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells

BACKGROUND: While chimeric antigen receptor (CAR)-T cell therapy is becoming widely used in hematological malignancies with remarkable remission rate, their high recurrence remains an obstacle to overcome. The role of consolidative transplantation following CAR-T cell-mediated remission remains cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qianwen, Xue, Lei, An, Furun, Xu, Hui, Wang, Li, Geng, Liangquan, Zhang, Xuhan, Song, Kaidi, Yao, Wen, Wan, Xiang, Tong, Juan, Liu, Huilan, Liu, Xin, Zhu, Xiaoyu, Zhai, Zhimin, Sun, Zimin, Wang, Xingbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086894/
https://www.ncbi.nlm.nih.gov/pubmed/35558072
http://dx.doi.org/10.3389/fimmu.2022.879030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086894/
https://www.ncbi.nlm.nih.gov/pubmed/35558072
http://dx.doi.org/10.3389/fimmu.2022.879030

Ejemplares similares